
EVOK
Healthcare · Drug Manufacturers - Specialty & Generic · $18.9M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · +23.1% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2025 | Time not confirmed | -0.45 | -0.45 | 0.0% |
| Aug 14, 2025 | Time not confirmed | -0.30 | -0.62 | -106.7% |
| May 12, 2025 | Before the open | -0.33 | -0.51 | -54.5% |
| Mar 12, 2025 | Before the open | -0.63 | -0.77 | -22.2% |
| Nov 7, 2024 | Before the open | -0.38 | -0.94 | -147.4% |
| Aug 8, 2024 | Before the open | -0.72 | -0.93 | -29.1% |
| May 14, 2024 | After the close | -0.21 | -0.17 | +19.0% |
| Mar 14, 2024 | After the close | -0.50 | -0.59 | -18.0% |
| Nov 9, 2023 | Before the open | -0.62 | -0.51 | +17.7% |
| Aug 10, 2023 | Before the open | -0.73 | -0.56 | +23.3% |
| May 15, 2023 | After the close | -0.58 | -0.67 | -15.5% |
| Mar 21, 2023 | After the close | -0.53 | -0.53 | 0.0% |
| Nov 9, 2022 | After the close | -0.66 |
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists,…
| -0.60 |
| +9.1% |
| Aug 10, 2022 | After the close | -0.60 | -0.71 | -18.3% |
| May 10, 2022 | After the close | -0.48 | -0.84 | -75.0% |
| Mar 8, 2022 | After the close | -0.96 | -0.72 | +25.0% |
| Nov 10, 2021 | After the close | -0.84 | -0.72 | +14.3% |
| Aug 12, 2021 | After the close | -0.96 | -0.84 | +12.5% |
| May 12, 2021 | After the close | -0.78 | -0.96 | -23.1% |
| Mar 11, 2021 | After the close | -1.62 | -1.08 | +33.3% |
| Nov 10, 2020 | Before the open | -1.02 | -0.96 | +5.9% |
| Aug 6, 2020 | Before the open | -0.96 | -3.36 | -250.0% |
| May 12, 2020 | Before the open | -0.60 | -0.84 | -40.0% |
| Mar 12, 2020 | Before the open | -0.72 | -0.72 | 0.0% |
| Nov 7, 2019 | Before the open | -1.08 | -0.84 | +22.2% |
| Aug 8, 2019 | Before the open | -1.44 | -1.08 | +25.0% |
| May 8, 2019 | After the close | -0.84 | -1.32 | -57.1% |
| Mar 6, 2019 | Before the open | -0.80 | -1.20 | -50.0% |
| Nov 13, 2018 | After the close | -0.96 | -1.08 | -12.5% |
| Aug 9, 2018 | After the close | -1.98 | -1.68 | +15.2% |
| May 14, 2018 | Before the open | -2.22 | -1.56 | +29.7% |
| Mar 7, 2018 | After the close | -2.78 | -0.24 | +91.4% |